Background
- Racial disparities are evident in prostate cancer (PCa), with Black men experiencing a higher incidence and worse survival compared to non-Hispanic White (NHW) patients.
- The molecular alterations that distinguish these groups remain incompletely characterized.
- Herein, we investigate the clinical-genomic features that potentially contribute to the differences in outcomes between Black and NHW patients with PCa.